APA (7th ed.) Citation

Rodriguez, M. T., Olmstead, S. J., McLaurin, K. A., Mactutus, C. F., & Booze, R. M. (2025). S-Equol: A novel therapeutic for HIV-1-associated gastrointestinal dysbiosis. NeuroImmune Pharmacology & Therapeutics, 4(4), 325. https://doi.org/10.1515/nipt-2024-0024

Chicago Style (17th ed.) Citation

Rodriguez, Mason T., Sarah J. Olmstead, Kristen A. McLaurin, Charles F. Mactutus, and Rosemarie M. Booze. "S-Equol: A Novel Therapeutic for HIV-1-associated Gastrointestinal Dysbiosis." NeuroImmune Pharmacology & Therapeutics 4, no. 4 (2025): 325. https://doi.org/10.1515/nipt-2024-0024.

MLA (9th ed.) Citation

Rodriguez, Mason T., et al. "S-Equol: A Novel Therapeutic for HIV-1-associated Gastrointestinal Dysbiosis." NeuroImmune Pharmacology & Therapeutics, vol. 4, no. 4, 2025, p. 325, https://doi.org/10.1515/nipt-2024-0024.